Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Innocare Pharma Inc.

United States 103 Carnegie Center Suite 209, 08540-6235, United States

About the sponsor

Innocare Pharma Inc., operating as Lumis International, is focused on clinical research in prurigo nodularis, a chronic inflammatory skin condition marked by persistent itch and nodular lesions. Its trial activity centers on adult participants affected by this debilitating dermatologic disorder.

  • Prurigo nodularis
  • Chronic pruritus
  • Inflammatory skin disease

The sponsor’s research interest is directed toward treatment options for symptom relief and disease control in skin-related inflammatory conditions.

About Specializations

Innocare Pharma Inc. runs clinical trials in conditions such as Neurodermatitis, Mantle cell lymphoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Mantle cell lymphoma

Recruiting

Phase 3 Study of Orelabrutinib with Rituximab and Bendamustine vs. Rituximab and Bendamustine in Treatment‑Naïve Mantle Cell Lymphoma Patients

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Innocare Pharma Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.